Case: BIOCON LTD. Building a biotech powerhouse Reasons for success of Biocon Ltd. in the past: Sequential growth strategy: Biocon added businesses like enzymes‚ biopharmaceuticals‚ research services and drug development that were interlinked. Consolidation of core skills: Biocon had consolidated its core skills in enzymes (known to be the building blocks of biotech)‚ established a footprint in biopharmaceuticals (which helped generate regular cash flow) and partnered with global firms (serving
Premium Pharmaceutical industry Clinical trial Pharmacology
Study on Organizational structure and Leadership style of Biocon Limited Contents Introduction of Biocon 2 Introduction to Organisational structures 3 Introduction to Leadership styles 4 Article Reviews 5 Organizational Structure Literature 5 1. Innovations in Organizational structure 5 2. Exploring the relationship between organization structure and perceived innovation in the Manufacturing Sector in India 6 3. Organization Design 7 Leadership Literature 11 1. At the end of the road
Premium Organizational structure Management Leadership
BIOCON – Launching a New Cancer Drug in India Brief Details Biocon who have successfully done the phase 2 trial of their new Cancer drug – Biomab are the first Indian company who have got break through success in the field of Head and neck Cancer drug. They still had to get their phase 3 trial done (which looks like a market norm‚ though not a legal requirement). Erbitux which was developed by Imclone Systems in US had granted license to Merck to distribute the drug to India. Erbitux had already
Premium Marketing Oncology Pharmacy
........................................................... 5 Current Status ..................................................................................................................................................... 6 Major Products of Biocon: .................................................................................................................................. 7 Biopharmaceuticals: ............................................................................................
Premium Biotechnology
3. Why is the recommended positioning strategy superior to other positioning strategies that might reasonably be considered? Exercise I (Pls. Note the change in the session order) Session#‚ Date 9&10 July 18‚ August 02 Assignment Questions Biocon 1. How has Biocon’s positioning and strategy evolved over the years? What role does
Premium Marketing Decision making Decision making software
company BIOCON B.V.Shashidhar 1PI10MBA27 Introduction to the company History Biocon India is incorporated as a joint venture between Biocon Biochemical’s Ltd. of Ireland and an Indian entrepreneur‚ Kiran Mazumdar-Shaw 1979 Biocon is the first Indian company to manufacture and export enzymes to USA and Europe 1989 Unilever plc. Acquires Biocon Biochemical’s
Premium Pharmaceutical industry Marketing Pharmacology
in the recruitment process. In the age of the internet the candidate market in the Biotechnology segment is very sensitive. I have taken eagle’s eye view on the process pertaining to Biocon. I have been part of the recruitment team at Biocon for more than 5 years and I have part of the change management team at Biocon where I was instrumental in bring about a new thought process of using social media in recruitment . I have consciously not mentioned few processes in the recruitment cycle because
Premium Recruitment Employment Biotechnology
Intro: Kiran Mazumdar-Shaw is an Indianentrepreneur. She is the Chairman & Managing Director of Biocon Limited a biotechnology company based in Bangalore (Bengaluru)‚ India. Edu Qual: Mazumdar-Shaw completed her schooling from the city’s Bishop Cotton Girl’s High School(1968). She wanted to join medical school but instead took up biology and completed her BSc Zoology Honours course from Mount Carmel College‚ Bangalore University (1973). She later did her post-graduation in Malting and Brewing
Premium Biotechnology Bangalore
Industry “Biotechnology in a powerful currency‚ stronger than the Euro or the Dollar‚ and what’s more‚ the only hardware you need is the human brain – let’s use our billion brains to our advantage.” – Kiran Mazumdar-Shaw‚ Founder and Chairman of Biocon‚ India’s first and largest biotechnology company The discovery of DNA in 1953 laid the foundation for modern biology but it was only in the early 1970’s‚ with the development of recombinant DNA technology at Stanford University that biotechnology
Premium Patent Biotechnology India
References: Biocon‚ 2008. Ms. Kiran’s Profile. [Online] Biocon India. Available at: http://www.biocon.com/biocon_press_kmprofile.asp?subLink=down [Accessed: 3 December 2009] Hisrich‚ R.D.‚ Peters‚ M.P.‚ Sheperd‚ D.A.‚ 2008. Entrepreneurship.7th ed. Singapore: McGraw Hill. Grundy‚ L.K. and
Premium Sociology